Stay updated on Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial
Sign up to get notified when there's something new on the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page.

Latest updates to the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a new history entry for revision v3.3.2 and removed the v3.2.0 entry.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding/operating status notice that appeared on the page. The clinical trial record and study details remain unchanged.SummaryDifference0.7%

- Check42 days agoChange DetectedVersion history shows updates to the study's recruitment status and overall study status, with corresponding edits to contacts/locations. These updates reflect the current state of the clinical trial on the record.SummaryDifference0.1%

- Check71 days agoChange DetectedUpdated the page to announce v3.2.0 with a funding-related operating status notice, replacing the previous v3.1.0. Key impact: users are informed about potential service disruptions and where to verify status.SummaryDifference12%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check93 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' item.SummaryDifference0.7%

Stay in the know with updates to Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page.